Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
ACS Med Chem Lett ; 8(6): 608-613, 2017 Jun 08.
Article in English | MEDLINE | ID: mdl-28626519

ABSTRACT

In our continued effort to discover and develop best-in-class Bruton's tyrosine kinase (Btk) inhibitors for the treatment of B-cell lymphomas, rheumatoid arthritis, and systemic lupus erythematosus, we devised a series of novel tricyclic compounds that improved upon the druglike properties of our previous chemical matter. Compounds exemplified by G-744 are highly potent, selective for Btk, metabolically stable, well tolerated, and efficacious in an animal model of arthritis.

2.
Bioorg Med Chem Lett ; 26(2): 575-579, 2016 Jan 15.
Article in English | MEDLINE | ID: mdl-26675441

ABSTRACT

BTK inhibitor GDC-0834 (1) was found to be rapidly metabolized in human studies, resulting in a suspension of clinical trials. The primary route of metabolism was through cleavage of the acyclic amide bond connecting the terminal tetrahydrobenzothiophene with the central linker aryl ring. SAR studies were focused on reducing metabolic cleavage of this amide, and resulted in the identification of several central aryl linker substituents that conferred improved stability. The most promising substituted aryl linkers were then incorporated into an optimized pyridazinone scaffold, resulting in the identification of lead analog 23, possessing improved potency, metabolic stability and preclinical properties.


Subject(s)
Protein Kinase Inhibitors/chemistry , Protein Kinase Inhibitors/pharmacology , Protein-Tyrosine Kinases/antagonists & inhibitors , Pyridazines/chemistry , Pyridazines/pharmacology , Pyrimidinones/chemistry , Pyrimidinones/pharmacology , Thiophenes/chemistry , Thiophenes/pharmacology , Agammaglobulinaemia Tyrosine Kinase , Animals , Dogs , Humans , Mice , Microsomes, Liver/metabolism , Models, Molecular , Protein Kinase Inhibitors/metabolism , Protein Kinase Inhibitors/pharmacokinetics , Protein-Tyrosine Kinases/metabolism , Pyridazines/metabolism , Pyridazines/pharmacokinetics , Pyrimidinones/metabolism , Pyrimidinones/pharmacokinetics , Rats , Thiophenes/metabolism , Thiophenes/pharmacokinetics
3.
Bioorg Med Chem Lett ; 25(6): 1333-7, 2015 Mar 15.
Article in English | MEDLINE | ID: mdl-25701252

ABSTRACT

SAR studies focused on improving the pharmacokinetic (PK) properties of the previously reported potent and selective Btk inhibitor CGI-1746 (1) resulted in the clinical candidate GDC-0834 (2), which retained the potency and selectivity of CGI-1746, but with much improved PK in preclinical animal models. Structure based design efforts drove this work as modifications to 1 were investigated at both the solvent exposed region as well as 'H3 binding pocket'. However, in vitro metabolic evaluation of 2 revealed a non CYP-mediated metabolic process that was more prevalent in human than preclinical species (mouse, rat, dog, cyno), leading to a high-level of uncertainly in predicting human pharmacokinetics. Due to its promising potency, selectivity, and preclinical efficacy, a single dose IND was filed and 2 was taken in to a single dose phase I trial in healthy volunteers to quickly evaluate the human pharmacokinetics. In human, 2 was found to be highly labile at the exo-cyclic amide bond that links the tetrahydrobenzothiophene moiety to the central aniline ring, resulting in insufficient parent drug exposure. This information informed the back-up program and discovery of improved inhibitors.


Subject(s)
Protein Kinase Inhibitors/chemistry , Protein-Tyrosine Kinases/antagonists & inhibitors , Pyrimidinones/chemistry , Thiophenes/chemistry , Agammaglobulinaemia Tyrosine Kinase , Animals , Benzamides/chemistry , Benzamides/metabolism , Binding Sites , Bridged Bicyclo Compounds, Heterocyclic/chemistry , Bridged Bicyclo Compounds, Heterocyclic/metabolism , Crystallography, X-Ray , Dogs , Half-Life , Humans , Mice , Microsomes, Liver/metabolism , Molecular Dynamics Simulation , Protein Binding , Protein Kinase Inhibitors/chemical synthesis , Protein Kinase Inhibitors/pharmacokinetics , Protein Structure, Tertiary , Protein-Tyrosine Kinases/metabolism , Pyrimidinones/chemical synthesis , Pyrimidinones/pharmacokinetics , Rats , Structure-Activity Relationship , Thiophenes/chemical synthesis , Thiophenes/pharmacokinetics
4.
J Med Chem ; 57(9): 3856-73, 2014 May 08.
Article in English | MEDLINE | ID: mdl-24779514

ABSTRACT

Spleen tyrosine kinase (Syk) is an attractive drug target in autoimmune, inflammatory, and oncology disease indications. The most advanced Syk inhibitor, R406, 1 (or its prodrug form fostamatinib, 2), has shown efficacy in multiple therapeutic indications, but its clinical progress has been hampered by dose-limiting adverse effects that have been attributed, at least in part, to the off-target activities of 1. It is expected that a more selective Syk inhibitor would provide a greater therapeutic window. Herein we report the discovery and optimization of a novel series of imidazo[1,2-a]pyrazine Syk inhibitors. This work culminated in the identification of GS-9973, 68, a highly selective and orally efficacious Syk inhibitor which is currently undergoing clinical evaluation for autoimmune and oncology indications.


Subject(s)
Indazoles/pharmacology , Protein Kinase Inhibitors/pharmacology , Protein-Tyrosine Kinases/antagonists & inhibitors , Pyrazines/pharmacology , Spleen/drug effects , Administration, Oral , Animals , Cells, Cultured , Drug Discovery , Humans , Indazoles/administration & dosage , Indazoles/chemistry , Magnetic Resonance Spectroscopy , Mice , Protein Kinase Inhibitors/administration & dosage , Protein Kinase Inhibitors/chemistry , Pyrazines/administration & dosage , Pyrazines/chemistry , Rats , Spectrometry, Mass, Electrospray Ionization , Spleen/enzymology , Structure-Activity Relationship
5.
PLoS Negl Trop Dis ; 7(3): e2093, 2013.
Article in English | MEDLINE | ID: mdl-23516645

ABSTRACT

Hansen's disease (leprosy) remains an important health problem in Brazil, where 34,894 new cases were diagnosed in 2010, corresponding to 15.3% of the world's new cases detected in that year. The purpose of this study was to use home visits as a tool for surveillance of Hansen's disease in a hyperendemic area in Brazil. A total of 258 residences were visited with 719 individuals examined. Of these, 82 individuals had had a previous history of Hansen's disease, 209 were their household contacts and 428 lived in neighboring residences. Fifteen new Hansen's disease cases were confirmed, yielding a detection rate of 2.0% of people examined. There was no difference in the detection rate between household and neighbor contacts (p = 0.615). The two groups had the same background in relation to education (p = 0.510), household income (p = 0.582), and the number of people living in the residence (p = 0.188). Spatial analysis showed clustering of newly diagnosed cases and association with residential coordinates of previously diagnosed multibacillary cases. Active case finding is an important tool for Hansen's disease control in hyperendemic areas, enabling earlier diagnosis, treatment, decrease in disability from Hansen's disease and potentially less spread of Mycobacterium leprae.


Subject(s)
Contact Tracing/methods , Epidemiological Monitoring , Leprosy/epidemiology , Leprosy/prevention & control , Mycobacterium leprae/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Brazil/epidemiology , Child , Child, Preschool , Cluster Analysis , Endemic Diseases , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Young Adult
6.
Am J Trop Med Hyg ; 86(1): 99-107, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22232458

ABSTRACT

Visceral leishmaniasis (VL) is endemic in large cities in Brazil, including Natal. We determined the prevalence of asymptomatic human infection with Leishmania infantum chagasi and associated environmental risks around Natal. Infection was detected by Leishmania skin test (LST) and anti-leishmanial antibodies in humans and anti-leishmanial antibodies in dogs. Amongst 345 humans, 24.6% were seropositive, and 38.6% were LST-positive. Prevalence of positive serology was similar in both sexes and across all ages. However, positive LST responses increased with age, suggesting that LST is long-lasting and cumulative. Multinomial logistic analysis showed that LST response varied with location (P = 0.007) and that males were more frequently LST-positive (P = 0.027). Indicators of lower socioeconomic status associated significantly with human infection. Furthermore, there was geographic coincidence of seropositive humans and dogs (r = 0.7926, P = 0.011). These data suggest that dog and human L. i. chagasi infection are intimately interrelated in environmental conditions associated with low income.


Subject(s)
Antibodies, Protozoan/blood , Asymptomatic Infections/epidemiology , Dog Diseases/epidemiology , Leishmania infantum/immunology , Leishmaniasis, Visceral/epidemiology , Animals , Brazil/epidemiology , Child , Child, Preschool , Disease Reservoirs , Dog Diseases/diagnosis , Dog Diseases/parasitology , Dogs , Female , Humans , Leishmaniasis, Visceral/diagnosis , Leishmaniasis, Visceral/parasitology , Leishmaniasis, Visceral/veterinary , Male , Prevalence , Rural Population , Skin Tests , Urban Population
7.
Nat Chem Biol ; 7(1): 41-50, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21113169

ABSTRACT

Bruton's tyrosine kinase (Btk) is a therapeutic target for rheumatoid arthritis, but the cellular and molecular mechanisms by which Btk mediates inflammation are poorly understood. Here we describe the discovery of CGI1746, a small-molecule Btk inhibitor chemotype with a new binding mode that stabilizes an inactive nonphosphorylated enzyme conformation. CGI1746 has exquisite selectivity for Btk and inhibits both auto- and transphosphorylation steps necessary for enzyme activation. Using CGI1746, we demonstrate that Btk regulates inflammatory arthritis by two distinct mechanisms. CGI1746 blocks B cell receptor-dependent B cell proliferation and in prophylactic regimens reduces autoantibody levels in collagen-induced arthritis. In macrophages, Btk inhibition abolishes FcγRIII-induced TNFα, IL-1ß and IL-6 production. Accordingly, in myeloid- and FcγR-dependent autoantibody-induced arthritis, CGI1746 decreases cytokine levels within joints and ameliorates disease. These results provide new understanding of the function of Btk in both B cell- or myeloid cell-driven disease processes and provide a compelling rationale for targeting Btk in rheumatoid arthritis.


Subject(s)
Arthritis, Experimental/drug therapy , Arthritis, Rheumatoid/drug therapy , B-Lymphocytes/drug effects , Benzamides/therapeutic use , Bridged Bicyclo Compounds, Heterocyclic/therapeutic use , Myeloid Cells/drug effects , Protein Kinase Inhibitors/therapeutic use , Agammaglobulinaemia Tyrosine Kinase , Animals , Arthritis, Experimental/immunology , Arthritis, Experimental/metabolism , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/metabolism , Autoantibodies/immunology , Autoantibodies/metabolism , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Benzamides/chemistry , Benzamides/pharmacology , Bridged Bicyclo Compounds, Heterocyclic/chemistry , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Cell Proliferation/drug effects , Enzyme Activation/drug effects , Interleukin-1beta/immunology , Interleukin-1beta/metabolism , Interleukin-6/immunology , Interleukin-6/metabolism , Mice , Myeloid Cells/immunology , Myeloid Cells/metabolism , Phosphorylation/drug effects , Protein Kinase Inhibitors/chemistry , Protein Kinase Inhibitors/pharmacology , Protein-Tyrosine Kinases/chemistry , Protein-Tyrosine Kinases/pharmacology , Protein-Tyrosine Kinases/therapeutic use , Tumor Necrosis Factor-alpha/immunology , Tumor Necrosis Factor-alpha/metabolism
8.
Am J Trop Med Hyg ; 82(2): 306-14, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20134009

ABSTRACT

Applied Spatial Statistics used in conjunction with geographic information systems (GIS) provide an efficient tool for the surveillance of diseases. Here, using these tools we analyzed the spatial distribution of Hansen's disease in an endemic area in Brazil. A sample of 808 selected from a universe of 1,293 cases was geocoded in Mossoró, Rio Grande do Norte, Brazil. Hansen's disease cases were not distributed randomly within the neighborhoods, with higher detection rates found in more populated districts. Cluster analysis identified two areas of high risk, one with a relative risk of 5.9 (P = 0.001) and the other 6.5 (P = 0.001). A significant relationship between the geographic distribution of disease and the social economic variables indicative of poverty was observed. Our study shows that the combination of GIS and spatial analysis can identify clustering of transmissible disease, such as Hansen's disease, pointing to areas where intervention efforts can be targeted to control disease.


Subject(s)
Geographic Information Systems , Leprosy/epidemiology , Brazil/epidemiology , Endemic Diseases , Humans , Risk Factors , Socioeconomic Factors , Time Factors
11.
Trans R Soc Trop Med Hyg ; 102(12): 1233-8, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18599101

ABSTRACT

Leptospirosis has been reported in rural areas of Brazil. However, there is limited information about the exposure risk or the risk of Leptospira infection for rural-based populations. A cross-sectional study was carried out in order to determine the prevalence and risk factors for prior Leptospira infection in a rural subsistence farming region of the state of Rio Grande do Norte, an area in which outbreaks of leptospirosis have occurred. Among 290 individuals enrolled, 44 (15.2%) had anti-Leptospira IgM antibodies as determined by IgM ELISA. Infection tended to occur with activities related to the rice fields (P=0.08). Our findings indicate that Leptospira infection occurs even in years of low rainfall, and may have an important impact among poor rural-based subsistence farmers in Brazil. Additional studies are needed to characterize the mode of transmission in this region.


Subject(s)
Agricultural Workers' Diseases/epidemiology , Leptospirosis/epidemiology , Adolescent , Adult , Agricultural Workers' Diseases/blood , Antibodies, Bacterial/blood , Biomarkers/blood , Brazil/epidemiology , Child , Cross-Sectional Studies , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoglobulin M/blood , Leptospira/immunology , Leptospirosis/blood , Male , Middle Aged , Prevalence , Risk Factors , Rural Health , Young Adult
12.
Acta Trop ; 90(2): 155-62, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15177141

ABSTRACT

American cutaneous leishmaniasis (ACL) was first reported from the south-western region of the state of Rio Grande do Norte in 1987. São Miguel municipality and adjacent areas have accounted for 90% of the American cutaneous leishmaniasis cases in the region since then. A population survey conducted in São Miguel and adjacent areas was undertaken to identify individuals with a history of ACL. The incidence of ACL, distribution by age and gender, clinical characteristics, family clustering, relationship to animals, association with skin test responses, and development of mucosal lesions were determined. Males and females were equally likely to be infected by Leishmania. Thirty-eight percent of the individuals tested were found to be Montenegro skin test positive. No difference in the Montenegro skin test was observed with gender, but the response increased with age. Among the 140 ACL cases treated in a 4-year period in São Miguel, five (3.6%) developed mucosal involvement. Sandflies capable of transmitting Leishmania were captured inside households and in the areas surrounding them. The high density of sandfly species potentially able to transmit Leishmania species and the age distribution of cases of cutaneous leishmaniasis suggest that transmission of the parasite occurred inside or in close proximity to houses.


Subject(s)
Insect Vectors , Leishmaniasis, Cutaneous/epidemiology , Psychodidae , Adolescent , Adult , Animals , Brazil/epidemiology , Case-Control Studies , Child , Female , Humans , Male , Rural Population , Urban Population
13.
Bioorg Med Chem Lett ; 14(3): 783-6, 2004 Feb 09.
Article in English | MEDLINE | ID: mdl-14741289

ABSTRACT

Bis-aryl ureas have been disclosed previously as a potent class of Raf kinase inhibitors. Modifications in the amide portion led to an improvement in aqueous solubility, an important characteristic for an oral drug. Based on this finding, we hypothesize that this portion of the molecule is directed towards the solvent in Raf-1.


Subject(s)
Enzyme Inhibitors/pharmacology , MAP Kinase Kinase Kinase 1 , Proto-Oncogene Proteins c-raf/antagonists & inhibitors , Urea/analogs & derivatives , Urea/pharmacology , Amides/chemical synthesis , Amides/pharmacology , Baculoviridae/genetics , Enzyme Inhibitors/chemical synthesis , Humans , MAP Kinase Kinase Kinases/antagonists & inhibitors , Molecular Structure , Pyridines/chemistry , Pyridines/pharmacology , Recombinant Proteins/antagonists & inhibitors , Solubility , Structure-Activity Relationship , Urea/chemical synthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...